Table-IV.
Genotype | Case | Control | OR (95% CI) | P | |
---|---|---|---|---|---|
-826C>T | -881A>G | ||||
CC | AA | 400 (55.7%) | 452 (63.0%) | 1.000 | -- |
CT | AA | 2 (0.3%) | 2 (0.3%) | 1.130(0.158-8.059) | 0.903 |
TT | AA | 0 (0.0%) | 0 (0.0%) | --- | -- |
CC | AG | 8 (1.1%) | 6 (0.8%) | 1.507(0.518-4.380) | 0.452 |
CT | AG | 246 (34.3%) | 220 (30.6%) | 1.264(1.008-1.584) | 0.043* |
TT | AG | 3 (0.4%) | 1 (0.1%) | 3.390 (0.351-32.722) | 0.291 |
CC | GG | 5 (0.7%) | 3 (0.4%) | 1.883(0.447-7.931) | 0.388 |
CT | GG | 3 (0.4%) | 1 (0.1%) | 3.390 (0.351-32.722) | 0.291 |
TT | GG | 51 (7.1%) | 33 (4.6%) | 1.746(1.105-2.761) | 0.017* |
significant.